# Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

> **NCT03215940** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 53 (actual)

## Conditions studied

- Chronic Pain, Widespread

## Interventions

- **DRUG:** Delta-9-Tetrahydrocannabinol
- **DRUG:** Cannabidiol
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03215940
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03215940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03215940, "Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03215940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*